Deriu Elisa, Boxx Gayle M, He Xuesong, Pan Calvin, Benavidez Sammy David, Cen Lujia, Rozengurt Nora, Shi Wenyuan, Cheng Genhong
Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, California, United States of America.
School of Dentistry, University of California, Los Angeles, Los Angeles, California, United States of America.
PLoS Pathog. 2016 May 5;12(5):e1005572. doi: 10.1371/journal.ppat.1005572. eCollection 2016 May.
Human influenza viruses replicate almost exclusively in the respiratory tract, yet infected individuals may also develop gastrointestinal symptoms, such as vomiting and diarrhea. However, the molecular mechanisms remain incompletely defined. Using an influenza mouse model, we found that influenza pulmonary infection can significantly alter the intestinal microbiota profile through a mechanism dependent on type I interferons (IFN-Is). Notably, influenza-induced IFN-Is produced in the lungs promote the depletion of obligate anaerobic bacteria and the enrichment of Proteobacteria in the gut, leading to a "dysbiotic" microenvironment. Additionally, we provide evidence that IFN-Is induced in the lungs during influenza pulmonary infection inhibit the antimicrobial and inflammatory responses in the gut during Salmonella-induced colitis, further enhancing Salmonella intestinal colonization and systemic dissemination. Thus, our studies demonstrate a systemic role for IFN-Is in regulating the host immune response in the gut during Salmonella-induced colitis and in altering the intestinal microbial balance after influenza infection.
人类流感病毒几乎仅在呼吸道中复制,但受感染个体也可能出现胃肠道症状,如呕吐和腹泻。然而,其分子机制仍未完全明确。利用流感小鼠模型,我们发现流感肺部感染可通过一种依赖于I型干扰素(IFN-I)的机制显著改变肠道微生物群谱。值得注意的是,肺部产生的流感诱导的IFN-I促进了肠道中 obligate厌氧细菌的消耗和变形菌门的富集,导致“失调”的微环境。此外,我们提供的证据表明,流感肺部感染期间肺部诱导的IFN-I抑制了沙门氏菌诱导的结肠炎期间肠道中的抗菌和炎症反应,进一步增强了沙门氏菌在肠道的定植和全身扩散。因此,我们的研究证明了IFN-I在沙门氏菌诱导的结肠炎期间调节肠道宿主免疫反应以及在流感感染后改变肠道微生物平衡方面的系统性作用。